Lipidor
0.23 SEK1 investor is following this company
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Revenue
80K
EBIT %
-19,312.5 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
LIPI
Daily low / high price
-
Market cap
6.66M SEK
Turnover
-
Volume
-
Financial calendar
Extraordinary general meeting
2024-05-21
Interim report
2024-05-22
General meeting
2024-06-05
Interim report
2024-08-28
Interim report
2024-11-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Cerbios-Pharma SA | 13.7 % | 13.7 % |
Aurena Laboratories AB | 5.6 % | 5.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Lipidor AB meddelar nytt datum för publicering av årsredovisning för 2023
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools